British Patient Capital invests $12.5 million in global health technology platform Proximie
Press release
British Patient Capital has invested in Proximie, the global health technology platform digitising operating rooms around the world, as part of a $80m Series C round.
The $12.5m investment has been made via Future Fund: Breakthrough, British Patient Capital’s £375m programme where it co-invests with private sector investors in innovative, R&D-intensive UK companies. The round was led by Advent Life Sciences and is British Patient Capital’s fourth life sciences deal following previous investments in Microbiotica, Epsilogen and Quell Therapeutics.
Headquartered in the UK, Proximie was founded by NHS surgeon Dr Nadine Hachach-Haram with a mission to improve access to quality medical intervention globally. After seeing first-hand the discrepancies that can arise between geographies, Dr Hachach-Haram – a fellow of the NHS Clinical Entrepreneur programme – developed Proximie to allow clinicians to virtually ‘scrub in’ to any operating room in the world. In turn, this global platform enables individuals to share best clinical practice in real time, to support continued medical education.
Future Fund: Breakthrough invests in highly innovative, R&D intensive UK companies that are looking to scale up, to help strengthen the UK’s position as a global science superpower. Proximie is driving the future of surgery, helping to improve accessibility to surgical expertise and learning across the globe. Our participation in this round will support Proximie as it continues to develop its innovative technology, and commercialises its activities around the world. Judith Hartley CEO, British Patient Capital
Our vision is to democratize surgery through better data by connecting every OR and Cath Lab in the world. We began this journey enabling surgeons to virtually join any OR. Now, we’re using this capability to digitize the operating room, bringing patients the collective expertise of the best surgeons in the world – where data collected and shared on Proximie can help them receive life-saving care, no matter where they live. Dr Nadine Hachach-Haram Founder and CEO of Proximie
Further Information
Notes to editors
About British Patient Capital
British Patient Capital is the trading name of British Patient Capital Limited, a wholly-owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. It forms part of the British Business Bank plc’s commercial arm.
Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. Launched in June 2018, British Patient Capital has £2.5bn to invest over 10 years in venture and venture growth capital to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. Find out more at britishpatientcapital.co.uk
British Business Bank plc and its subsidiary entities are not banking institutions and do not operate as such. They are not authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website.
British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.
This investment from British Patient Capital does not amount to any endorsement or warranty from British Patient Capital, the British Business Bank plc, or the government of the UK.
About Proximie
Proximie is a global health technology platform focused on digitizing operating and diagnostic rooms. Proximie’s mission is to save lives by sharing the world’s best clinical practice. Every Proximie procedure can be recorded, analysed and leveraged for future use to help inform best practice.
By connecting operating rooms globally, Proximie is creating a rich, insightful data set which naturally feeds best practices into the entire healthcare ecosystem, delivering global connected surgical care.
Founded by Dr Nadine Hachach-Haram, Proximie has now conducted tens of thousands of surgical procedures – in every speciality – and been deployed in over 500 hospitals in across 100 countries in five continents.
Proximie has contracts with over 35 major medical device companies – with access to 90% of operating rooms and diagnostic suites in the UK, US, and EU.
For more information please visit proximie.com or follow @ProximieAR on Twitter.
Latest news
-
Read more about British Patient Capital – Full Year Results for the period ending 31 March 2024 Press release
04 November 2024 -
Read more about British Patient Capital announces £8m investment into Nuclera as part of a $75m Series C financing round Press release
16 October 2024 -
Read more about British Patient Capital announces investment into Purespring Therapeutics as part of £80m Series B financing round Press release
09 October 2024